Preview

Вопросы современной педиатрии

Расширенный поиск

ВЛИЯНИЕ ПРОБИОТИЧЕСКОЙ КУЛЬТУРЫ LACTOBACILLUS RHAMNOSUS GG НА ИММУННЫЙ ОТВЕТ ОРГАНИЗМА

Аннотация

В статье приводится обзор данных о влиянии пребиотической культуры Lactobacillus rhamnosus GG на состояние кишечного биоценоза. Особо отмечено влияние L. rhamnosus GG на функционирование иммунной системы.
Ключевые слова: пребиотики, Lactobacillus rhamnosus GG, иммунный ответ.Обзор
(Вопросы современной педиатрии. 2009; 8(2):54-58)

Об авторе

А.В. Суржик
ОАО «Компания Юнимилк», Москва
Россия


Список литературы

1. Hatakka K., Saxelin M. Probiotics in intestinal and non-intestinal infectious diseases – clinical evidence. Curr. Pharm. Des. 2008; 14: 1351–1367.

2. Hooper L., Wong M. Thelin A. et al. Molecular analysis of commensal host microbial relationships in the intestine. Science. 2001; 291: 881–884.

3. Marteau P., Seksik P. Tolerance of probiotics and prebiotics. J. Clin. Gasroenterol. 2004; 38: 67–69.

4. Goldin B.R., Gorbach S.L., Saxelin M., et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 1992; 37 (1): 121–128.

5. Lim K. Antimicrobial susceptibility of Bifidobacteria. J. Dairy Sci. 1993; 76: 2168–2174.

6. Saxelin M. Safety of commercial products with viable Lactobacillus strains. Infec. Dis. Clin. Pract. 1996; 5: 331–335.

7. Szajewska H., Kotovska M., Mrukowicz J. et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr. 2001; 138: 361–365.

8. Hatakka K., Savilahti E., Ponka A. et al., Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomized trial. BMJ. 2001; 322: 1351–1367.

9. Saxelin M. LGG – Summation: Lactobacillus GG and its health effects. Helsinki: Valio Lt. 2002. 60 p.

10. Saavedra J.M., Long term consumption of infants formulas containing live probiotic bacteria: tolerance and safety. Am. J. Clin. Nutr. 2004; 79: 261–267.

11. Isolauri E., Suomalainen H. Probiotics: effects on immunity. Am. J. Clin. Nutr. 2001; 73: 444–450.

12. Guandolini S. Lactobacillus GG administered in oral rehidratation solution to children with acute diarrhea. JPGN. 2000; 30: 54–60.

13. Vanderhoof J.A., Whitney D.B., Antonson D.L. et al. Lactobacillus GG in the prevention of antibiotic-associated diarroea in children. J. Pediatr. 1999; 135: 564–568.

14. Бельмер С.В., Хавкин А.И. Детская гастроэнтерология на компакт-диске. М.: Пасомар. 2003. 400 с.

15. Szajewska H., Skorka A., Ruszczynski M. et al., Meta-analysis: Lactobacillus GG for treating acute diarrhea in children. Aliment. Pharmacol. Ther. 2007; 25: 871–881.

16. Albers R., Antoine J. Bourdet-Sicard R. et al. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 2005; 94: 452–481.

17. Oberhelman R. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J. Pediatr. 1999; 134: 15–20.

18. Kekkonen R., Vasankari T., Vuorimaa T. et al. The effect of probiotic on respiratory infection and gastrointestinal symptoms during training in marathon runners. Int. J. Sport. Nutr. Exerc. Metab. 2007; 17: 352–363.

19. Isolauri E., Joensuu J., Suomalainen H. et al. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus GG. Vaccine. 1995; 13: 310–312.

20. De Vrese M., Winkler P., Rautenberg P. et al. Effect of Lactobacillus gasseri PA 16/18, Bifidobacterium longum SP 07/3. Clin. Nutr. 2005; 24: 481–491.

21. Kaila M., Isolauri E., Saxelin M., et al. Viable versus inactivated Lactobacillus GG in acute rotavirus diarrhea. Arch. Dis. Child. 1995; 72: 51–53.

22. Majamaa H., Isolauri E., Saxelin M., et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 1995; 20 (3): 333–338.

23. Miettinen M., Lactobacilli and Streptococci activate NF–kappa B and STAT signaling pathways in human macrophages. J. Immunol. 2000; 1 (64): 253–258.

24. Корниенко Е.А., Дроздова С.Н. Серебряная Н.Б. Пробиотики как способ повышения эффективности эрадикации Helicobacter pylori у детей. Фарматека. 2005; 7: 68–70.

25. Kalliomäki M., Salminen S., Poussa T., et al. Probiotics and prevention of atopic disease: 4year follow up of a randomized placebo controlled trial. Lancet. 2003; 361 (9372): 1869–1871.

26. Myllyluoma E. LGG and immune response. Helsinki: Valio Ltd. 2008.


Для цитирования:


Суржик А. ВЛИЯНИЕ ПРОБИОТИЧЕСКОЙ КУЛЬТУРЫ LACTOBACILLUS RHAMNOSUS GG НА ИММУННЫЙ ОТВЕТ ОРГАНИЗМА. Вопросы современной педиатрии. 2009;8(2):54-58.

For citation:


Surzhik A. INFLUENCE OF PROBIOTIC CULTURE LACTOBACILLUS RHAMNOSUS GG (LGG) ON IMMUNE RESPONSE OF ORGANISM. Current Pediatrics. 2009;8(2):54-58. (In Russ.)

Просмотров: 422


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)